Trade Summary

3 days ago, Lu Hongbo, serving as Dir at Arrowhead Pharmaceuticals, Inc. (ARWR), sold 2,970 shares at $76.88 per share, for a total transaction value of $228,334.00. Following this transaction, Lu Hongbo now holds 52,012 shares of ARWR.

This sale represents a 5.00% decrease in Lu Hongbo's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 12, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 14, 2026 at 7:05 PM ET, 2 days after the trade was made.

Arrowhead Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.